High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NEUROLOGY
Volume 22, Issue 4, Pages 672-e41
Publisher
Wiley
Online
2014-12-22
DOI
10.1111/ene.12627
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort
- (2014) Cecilie Dobloug et al. ANNALS OF THE RHEUMATIC DISEASES
- Demographic Features of Japanese Patients with Sporadic Inclusion Body Myositis: A Single-center Referral Experience
- (2014) Hirotaka Nakanishi et al. INTERNAL MEDICINE
- Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features
- (2013) Stefen Brady et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- An Antibody Blocking Activin Type II Receptors Induces Strong Skeletal Muscle Hypertrophy and Protects from Atrophy
- (2013) E. Lach-Trifilieff et al. MOLECULAR AND CELLULAR BIOLOGY
- 188th ENMC International Workshop: Inclusion Body Myositis, 2–4 December 2011, Naarden, The Netherlands
- (2013) M.R. Rose NEUROMUSCULAR DISORDERS
- HLA-C alleles confer risk for anti-citrullinated peptide antibody-positive rheumatoid arthritis independent of HLA-DRB1 alleles
- (2013) Gry B. N. Nordang et al. RHEUMATOLOGY
- Update on sporadic inclusion body myositis
- (2011) R. Hohlfeld BRAIN
- A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities
- (2011) Fieke M. Cox et al. BRAIN
- Long-term observational study of sporadic inclusion body myositis
- (2011) O. Benveniste et al. BRAIN
- The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype
- (2011) A. Rojana-udomsart et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Dysphagia in Inflammatory Myopathy: Self-report, Incidence, and Prevalence
- (2011) Kylie Patricia Mulcahy et al. DYSPHAGIA
- Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: a 30-year epidemiologic study of histology-proven cases
- (2011) Ju Ann TAN et al. International Journal of Rheumatic Diseases
- Increase in number of sporadic inclusion body myositis (sIBM) in Japan
- (2011) Naoki Suzuki et al. JOURNAL OF NEUROLOGY
- Inclusion body myositis in Alzheimer’s disease
- (2010) P. M. Roos et al. ACTA NEUROLOGICA SCANDINAVICA
- International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009
- (2010) Olivier Benveniste et al. NEUROMUSCULAR DISORDERS
- Detecting dysphagia in inclusion body myositis
- (2009) F. M. Cox et al. JOURNAL OF NEUROLOGY
- Inclusion body myositis: old and new concepts
- (2009) A A Amato et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype
- (2009) Frank L. Mastaglia et al. NEUROMUSCULAR DISORDERS
- Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer’s and Parkinson’s disease brains
- (2008) Valerie Askanas et al. ACTA NEUROPATHOLOGICA
- Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis
- (2008) Merrilee Needham et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Sporadic inclusion body myositis: Phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases
- (2008) M Needham et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started